# Disentangling on and off-target binding in flortaucipir PET: a voxel-to-voxel P-tau, ferric iron, and MAO-B histology-to-flortaucipir PET comparison

**Authors:** Yuheng Chen, Renaud La Joie, Felipe L. Pereira, Ganna Blazhenets, Lucile Zhu, Salvatore Spina, William W. Seeley, Helmut Heinsen, Daniela Ushizima, Duygu Tosun, Gil D. Rabinovici, Lea T. Grinberg

PMC · DOI: 10.1007/s00401-026-02983-x · Acta Neuropathologica · 2026-02-25

## TL;DR

This study investigates why Flortaucipir PET scans sometimes detect signals unrelated to tau protein, comparing them with brain tissue data to better interpret the results.

## Contribution

The study introduces a voxel-to-voxel comparison method to analyze off-target Flortaucipir binding in relation to tau, iron, and MAO-B in various brain diseases.

## Key findings

- Flortaucipir signal in Alzheimer's disease moderately correlates with tau pathology but also with ferric iron and MAO-B.
- In non-AD tauopathies and FTLD-TDP-43, Flortaucipir signal correlates more with ferric iron and MAO-B than with tau.
- Off-target Flortaucipir signals are not fully explained by the studied factors, suggesting other contributors.

## Abstract

Flortaucipir PET imaging has significantly advanced our ability to visualize tau pathology in vivo. However, off-target Flortaucipir signal remains a considerable challenge for interpreting of imaging results, particularly in non-Alzheimer's tauopathies and non-tau pathologies. To better understand this off-target signal, we used an innovative voxel-to-voxel correlation approach, analyzing thousands of histology-Flortaucipir pairs from individual cases. This allowed us to quantitatively assess the relationship between Flortaucipir PET signal and three key biological factors: histological tau burden (CP-13 phospho-tau), ferric iron (Perls’ Prussian blue), and monoamine oxidase B (MAO-B). Our study included individuals with Alzheimer's disease (AD), various non-AD tauopathies, and a case of FTLD-TDP-43 type A. In AD, Flortaucipir signal showed a significant but moderate correlation with histological tau pathology, suggesting that while tau is a major contributor, other biological factors also influence Flortaucipir binding in AD. Conversely, in non-AD tauopathies and FTLD-TDP-43, correlations between Flortaucipir signal and tau pathology were weak or negligible. Instead, Flortaucipir signal correlated more strongly with ferric iron and MAO-B. However, these factors did not fully explain all the off-target signals, implying other unknown contributors are likely involved. These findings underscore the complexity of interpreting Flortaucipir PET scans. A thorough understanding of off-target binding mechanisms is crucial for improving the diagnostic accuracy of Flortaucipir PET and its specificity.

The online version contains supplementary material available at 10.1007/s00401-026-02983-x.

## Linked entities

- **Proteins:** MAPT (microtubule associated protein tau), MAOB (monoamine oxidase B)
- **Chemicals:** ferric iron (PubChem CID 29936)
- **Diseases:** Alzheimer's disease (MONDO:0004975)

## Full-text entities

- **Genes:** MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, OPN1MW (opsin 1, medium wave sensitive) [NCBI Gene 2652] {aka CBBM, CBD, COD5, GCP, GOP, OPN1MW1}, PSPN (persephin) [NCBI Gene 5623] {aka PSP}, MAOA (monoamine oxidase A) [NCBI Gene 4128] {aka BRNRS, MAO-A}, TARDBP (TAR DNA binding protein) [NCBI Gene 23435] {aka ALS10, TDP-43}, GRN (granulin precursor) [NCBI Gene 2896] {aka CLN11, FTD2, GEP, GP88, PCDGF, PEPI}, MAOB (monoamine oxidase B) [NCBI Gene 4129], Maob (monoamine oxidase B) [NCBI Gene 109731] {aka 6330414K01Rik, MAO-B}
- **Diseases:** FTLD-TDP-43 type A. (MESH:D057180), neurological disorder (MESH:D009461), PSP-RS (MESH:D013494), neurofibrillary tangles (MESH:D055956), chronic traumatic encephalopathy (MESH:D000070627), TDP (MESH:D016171), sporadic and inherited neurodegenerative disorders (MESH:D020271), dementia (MESH:D003704), corticobasal degeneration (MESH:D000088282), PET (MESH:D014012), Axis I psychiatric disorder (MESH:D001523), FTLD (MESH:D057174), AD (MESH:D000544), 4R tauopathy (MESH:D024801), TDP proteinopathies (MESH:D057165), Neurodegenerative Disease (MESH:D019636), primary progressive aphasia (MESH:D018888), PH (MESH:D001041), astrogliosis (MESH:D005911), death (MESH:D003643), TDP-43 (MESH:D057177)
- **Chemicals:** DAB (MESH:C000469), 18F (MESH:C000615276), iron (MESH:D007501), AV-1451 (MESH:C000591008), azide (MESH:D001386), Ser (MESH:D012694), [18F]-THK5351 (MESH:C000608225), CP-13 phospho (-), P (MESH:D010758)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S305I

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935771/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935771/full.md

---
Source: https://tomesphere.com/paper/PMC12935771